Total planned funding: $86,871,334
Clear active filters
Democratic Republic of the Congo
Treatment
HTXD: Treatment: ARV Drugs
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Democratic Republic of the Congo | $86,871,334 |
Organizational Types
| Private Contractor | $86,161,208 |
| Own Agency | $571,406 |
| NGO | $113,019 |
| Unknown | $19,116 |
| Other USG Agency | $6,585 |
| Multi-lateral Agency | $0 |
| University | $0 |
| FBO | $0 |
Program Areas
| Treatment | $86,871,334 |
Budget Codes
| HTXD: Treatment: ARV Drugs | $86,871,334 |
Top Partner Programs
Chemonics International:
$75,877,907
Countries/Regions
Partnership for Supply Chain Management:
$10,283,301
Countries/Regions
Democratic Republic of the Congo
| 2013 | $1,400,000 |
| 2014 | $3,183,301 |
| 2015 | $5,700,000 |
USG Aggregated Agencies:
$340,128
Countries/Regions
Democratic Republic of the Congo
| 2015 | $45,595 |
| 2016 | $109,546 |
| 2017 | $69,739 |
| 2018 | $115,248 |
U.S. Agency for International Development:
$195,654
Countries/Regions
Democratic Republic of the Congo
| 2013 | $69,400 |
| 2014 | $73,584 |
| 2019 | $52,670 |